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1. Introduction
  Adenoid cystic carcinoma (ACC) of lacrimal gland is the 
most common and most malignant tumor in malignant 
epithelial tumour of lacrimal gland. The incidence rate of 
ACC of lacrimal gland takes up 29% of epithelial tumour of 
lacrimal gland, ranking as the second following pleomorphic 
adenoma[1,2]. ACC of lacrimal gland is insensitive to 
conventional radiotherapy and chemotherapy, therefore 
surgical treatment is mainly used. However, ACC of lacrimal 
gland has high invasion growing along nerve[3]. It can’t 
be eradicated by operation, and the recurrence rate after 
operation is high with poor long-term effect. Therefore, 
exploring new treatment method has become the new 
direction of ACC research.
  Extract of Ginkgo biloba (EGB) has inhibitory effect on 
tumor cell proliferation, induces apoptosis of various 
tumor cells[4,5], and strengthens the antitumor effect of 
chemotherapeutic drugs. However, there is no report 
about the antitumor effect of EGB on ACC nor about its 
mechanism. Survivin, a new apoptosis inhibitor found in 
recent years, has the apoptosis inhibition effect through 
inhibiting the activity of Caspas-3 and Caspas-7 in the 
downstream of Caspas cascade reaction, which is also a hot 
spot in tumor related gene research[6,7]. This study explored 
the possible antitumor mechanism of EGB by observing the 
influence of EGB on proliferation and apoptosis of ACC-2 
cell and Survivin gene expression in ACC of lacrimal gland, 
which provided experimental and theoretical basis for 
further clinical application.
Objective: To explore the influence of extract of Ginkgo biloba (EGB) on the proliferation, 
apoptosis of ACC-2 cell and Survivin gene expression in adenoid cystic carcinoma (ACC) of 
lacrimal gland. Methods: ACC-2 cell in human with ACC of lacrimal gland was in vitro cultured. 
MTT method was used for cell proliferation detection. Annexin V/PI double-staining flow 
cytometer was used to detect cell apoptosis and cell cycle. Survivin gene expression was analyzed 
by RT-PCR and Western blotting. Results: EGB had inhibitory effect on the proliferation of 
ACC-2 cell with significant dose-effect relationship, and there was statistical difference when 
compared with the control group (P<0.01). The inhibitory concentration 50 % (IC50) is 88 mg/L. 
The flow cytometer test indicated that EGB can gradually increase ACC-2 cell in G0-G1 stage 
and decrease it in G2-M and S stage. With the increase of dose, the apoptosis rate of ACC-2 cell 
was obviously increased (P<0.05 or P<0.01). EGB had certain inhibitory effect on Survivin gene 
expression of ACC-2 cell, and Survivin gene expression was decreased with the increasing of the 
EGB concentration (P<0.01). Conclusions: EGB can effectively inhibit Survivin gene expression 
of ACC-2 cell in human with ACC of lacrimal gland, induce the apoptosis of ACC-2 cell and 
inhibit tumor cell proliferation.
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2. Materials and methods
2.1. Materials
2.1.1. Drugs and reagents  
  Extract of Ginkgo biloba (EGB761, trade name: Ginaton) 
was produced by Dr Willmar Schwabe Pharmaceutical 
Factory (Germany, batch number: 1140808). RT-PCR kit 
was purchased from Germany Qiagen Company. Annexin 
V-FITC apoptosis detection kit was purchased from Beijing 
Baosai Biotechnology Co., Ltd. Survivin antibody was from 
America Santa Cruz Company; RPMI-1640 culture solution 
and fetal calf serum were purchased from American Gibco 
Company. MTT, dimethyl sulfoxide (DMSO) and agarose were 
from America Amresco Company; Trizol total RNA extraction 
reagent was from Invitrogen Company; Taq DNA polymerase, 
Oligod and RNAsin were purchased from Promage Company; 
Primers were synthesized by Shanghai Sangon Biotechnology 
Co., Ltd.  
 
2.1.2. Cell strains 
  ACC-2 cells- human ACC of lacrimal gland were purchased 
from Shanghai Institutes for Biological Sciences, Chinese 
Academy of Sciences. Under the condition of 37 曟, 5% CO2 
and saturated humidity, the cells were cultured in RPMI-
1640 culture solution with 10% fetal calf serum and 2% 
Glutamine.
2.1.3. Instrument and equipment 
  CO2 incubator (MCO175, SANYO); inverted microscope (桖
-70, Olympus); horizontal flow clean bench (ZHJH-2112); 
flow cytometry (FACS Calibur, Becton Dickinson); PCR 
amplifier (Roche); ELX800 enzyme-labeling instrument.
2.2. Methods
2.2.1. Cell proliferation detected by MTT method
  2伊107/mL cell suspension was made with ACC-2 cells in 
logarithmic growth phase. Then the cell suspension was 
inoculated into a 96-well culture plate with 100 毺L in each 
well for 24-hour culture. 100 毺L EGB was added to make 
the final concentration was 0, 10, 20, 40, 80 and 160 mg/L, 
respectively. At the same time, control well and zero well 
was set, and there were 6 parallel holes in each group. After 
another 48-hour culture, 20 毺L MTT solution (5 g/L) was 
added into each well. The supernatant was absorbed after 
4-hour culture. Then, 200 毺L DMSO was added into each 
well. The culture plate was fully oscillated. After the reaction 
stopped, absorbance value (A value) at 490 nm was detected 
by enzyme-labeling instrument. The cell proliferation 
inhibition rate was calculated by the following formula. 
   Inhibition rate= (A value of the control group-A value of 
the drug group)/A value of the control group伊100%
2.2.2. Cell apoptosis rate detected by Annexin V/PI double 
staining flow cytometry  
  1伊106/mL cell suspension was made with ACC-2 cells in 
logarithmic growth phase. Then the cell suspension was 
inoculated into a 12-well culture plate with 2 mL in each 
well. 100 毺L EGB was added to make the final concentration 
was 0, 10, 40 and 160 mg/L, respectively. After cultured for 
48 hours, the cell concentration was regulated to 1伊106/mL. 
At 4 曟, 1 mL cell suspension was centrifuged at the speed 
of 1 000 r/min for 10 minutes, and then the supernatant 
was abandoned. 1 mL cold PBS was added to resuspend 
cells and repeat centrifugation and supernatant abandon. 
200 毺L binding buffer was added for resuspension, then 
10 毺L Annexin V-FITC and 5 毺L PI were added and well 
mixed. After dark incubation at room temperature for 15 
minutes, 300 毺L binding buffer was added. Cell apoptosis 
rate was detected immediatedly by flow cytometry, and the 
cell cycle was analyzed. 
2.2.3. Survivin mRNA expression detected by RT-PCR  
  ACC-2 cells in logarithmic phase were cultured for 24 
hours. EGB was added to make the final concentration 
was 0, 10, 40 and 160 mg/L, respectively. After cultured 
for another 48 hours, total RNA was extracted by Trizol 
reagent. RNA was detected by electrophoresis. cDNA was 
synthesized by reverse transcription. Survivin was amplified 
by PCR with cDNA as the template and 毬-action as the 
internal reference gene. The upstream primer of Survivin: 
5’-GGCACCA- GAGGCAGTAACCA-3’, downstream primer: 
5’-GGACCTTCGGTGACTGATGATCTAA-3’; The upstream 
primer of 毬-action: 5’-AACGGATTTGGTCGTATTGGG-3’, 
downstream primer: 5’-AGTCTT- TCTGGGTGGCAGTGAT-3’. 
PCR was run for 35 cycles with 5 minutes per 95 曟 
predenaturation, 30 s/ 94 曟 denaturation, 30 s/58 曟 
annealing and 30 s/72 曟 elongation; 12 毺L PCR product was 
conducted agarose gel electrophoresis with 2% agarose. Gel 
imaging analysis system was used to observe and record the 
results.
2.2.4. Survivin gene expression detected by Western blotting  
  1伊107 ACC-2 cells after 48 hours reaction with 0, 10, 
40 and 160 mg/L EGB, respectively were collected. 
200 毺L protein lysis solution was added. After 1 hour lysis at 
4 曟, 20 minutes centrifugation at 4 曟 with the speed of 
12 000 r/min was conducted, and then the supernatant was 
taken. Protein concentration was detected by Coomassie 
Brilliant Blue protein detection method. After 10 minutes 
total protein denaturation of the 80 毺g sample, SDS-PAGE 
gel electrophoresis was conducted. The isolated protein was 
transferred to PVDF membrane by electrotransfer. It was 
sealed for 1 hour with 5% BSA at 37 曟. Then anti-Survivin 
monoclonal antibody was added and incubated for 16 hours 
at 4 曟, and then the membrane was washed three times. 
Then the goat anti mouse secondary antibody was added 
and incubated for 1 hour at 37 曟, and then the membrane 
was washed three times. Chemiluminescence technique was 
used to detect and analyze the results. Relative quantitative 
analysis was conducted for the gray scale of the protein 
strips using 毬-action strip as the reference. Relative 
content of Survivin=gray value of Survivin/gray value of 毬
-action, Inhibition ratio=1- Relative content of Survivin in 
drug group/ Relative content of Survivin in control group.
2.2.5. Statistical analysis  
  Statistical treatment was conducted by SPSS15.0 software. 
Measurement data was expressed as mean暲SD. t test or 
single factor analysis of variance was used. Chi-square test 
was used for the rate comparison. A P value of <0.05 was 
considered as statistical significance.
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3. Results
3.1. Inhibitory action of EGB on ACC-2 cell proliferation
  EGB in different concentration has inhibitory effect on the 
in vitro proliferation of ACC-2 cell, and with the increase of 
EGB concentration, the inhibitory action was also increased, 
showing significant dose-effect relationship. There was 
statistical difference between the drug group in different 
doses and the control group (t=11.67, 16.31, 22.01, 24.18, 
26.68, P<0.01). The IC50 was 88 mg/L by Logit method (Table 
1). 
Table 1 
Inhibitory action of EGB on ACC-2 cell proliferation (mean依SD, 
n=6). 
Groups A value Inhibitory rate (%)
Control group 0.835依0.037 -
EGB group 10 mg/L 0.643依0.016b 22.99
20 mg/L 0.561依0.018b 32.81
40 mg/L 0.457依0.020b 45.27
80 mg/L 0.415依0.021b 50.30
160 mg/L 0.382依0.019b 54.25
b: P<0.01 vs. control group.
3.2. Influence of EGB on ACC-2 cell cycle and apoptosis 
  EGB can gradually increase ACC-2 cell in G0-G1 stage and 
decrease that in G2-M and S stage. With the increase of dose, 
the apoptosis rate of ACC-2 cell was obviously increased 
(氈
2=2.97, 5.62, 7.96, P<0.05 or P<0.01, Table 2). 
Table 2 
Influence of EGB on ACC-2 cell cycle and apoptosis.  
Groups G0-G1 stage 
(%)
G2-M stage 
(%)
S stage 
(%)
Apoptosis 
rate (%)
Control group 46.37 8.11 45.52   8.68
EGB group 10 mg/L 52.97 7.15 39.88 17.96
40 mg/L 56.68 5.93 37.39 21.72a
160 mg/L 61.38 4.59 34.03 24.53b
a: P<0.05, b: P<0.01 vs. control group. 
3.3. Influence of EGB on Survivin gene expression by Western 
blotting analysis
  Survivin gene expression significantly reduced as the 
EGB concentration increases, showing obvious dose-effect 
relationship (Figure 1).
Survivin
毬-action
EGB (mg/L)             0                          10                         40                     160
Figure 1. Influence of EGB on Survivin gene expression analyzed by 
Western blotting. 
3.4. Influence of EGB on the relative content of Survivin gene 
in ACC-2 cell and inhibitory rate 
  EGB in different concentration has inhibitory effect on the 
Survivin gene of ACC-2 cell, and with the increase of EGB 
concentration, the inhibitory action was also increased, 
showing significant dose-effect relationship. There was 
statistical difference between the drug group in different 
doses and the control group (t=8.77, 10.04, 15.59, P<0.01, 
Table 3).
Table 3
Influence of EGB on the relative content of Survivin gene in ACC-2 
cell and inhibitory rate (mean依SD, n=6).  
Groups Relative content Inhibitory rate (%)
Control group 0.85依0.06
EGB group 10 mg/L  0.52依0.07b 38.82
40 mg/L 0.44依0.08b 48.24
160 mg/L 0.31依0.06b 63.53
b: P<0.01 vs. control group.
4. Discussion
  ACC of lacrimal gland is a highly invasive tumor with poor 
prognosis, the pathogenesis and treatment of which is an 
important topic demanding prompt solution in clinic. After 
years of research, no effective therapeutic tool has been 
found. Having the advantages like multi-channel, multi-
target and low toxicity, the traditional Chinese medicine 
has become a hot spot in tumor research. EGB is the active 
principle separated and purified from Ginkgo biloba, mainly 
containing flavonoid and lactone components. EGB is mainly 
used for cardiovascular and cerebrovascular disease and 
peripheral circulation disorder[8,9]. In recent years, some 
researches proved that EGB has certain antineoplastic 
activity, having lethal effect on gastric cancer[10], liver 
cancer[11], intestinal cancer[12] and breast cancer[13], but the 
precise mechanism of antitumor effect was unclear. EGB 
in different concentration has inhibitory effect on the in 
vitro proliferation of ACC-2 cell with significant dose-effect 
relationship (P<0.01). The IC50 was 88 mg/L by Logit method.
  Some research indicated that the development of tumor 
is not only related with the abnormal proliferation and 
differentiation of cell, but also related with apoptosis[14,15]. 
Cell apoptosis is a physiological cell suicide process in order 
to maintain organism balance, which is regulated by gene. In 
this study, the Annexin V/PI double staining flow cytometry 
detection indicated that EGB promoted the apoptosis of the 
ACC-2 cell and changed the cell cycle distribution of ACC-2 
cell. After 48h effect of EGB, the percentage of cells in G0-
G1 stage was significantly increased while the percentage of 
cells in S stage was significantly reduced, and this retarding 
effect has certain dose dependency. This indicated that the 
proliferation inhibitory effect of EGB on ACC-2 cell maybe 
related with EGB changed the cell cycle distribution, which 
is, stagnating most cells in cell differentiation stage (G1 
stage) and blocking the transform to S stage which reduced 
the DNA synthesis and mitosis at the same time promoted 
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the differentiation.
  Survivin is one of the cell regulatory factors having the 
strongest anti-apoptosis effect. Located in Chromosome17q25 
and composed by 3 introns and 4 exons, Survivin can 
encode 142 amino acids[16-19] with the length of 14.7 kb. 
Survivin is a member of Inhibitor of apoptosis proteins 
(IAPs). Survivin  can inhibit the activation of Caspase-3 and 
block cell apoptosis consequently, the overexpression of 
which maybe the main factor for the tumor development and 
poor prognosis[20,21]. Researchers found that[22,23] Survivin 
selectively express in malignant tumor, and with increase 
of the malignant degree, Survivin expression increases. 
But Survivin doesn’t or seldom express in normal tissue. 
In this study, using Survivin as the research target, EGB in 
different concentration was acted on ACC-2 cell with ACC 
of lacrimal gland. Survivin gene expression was analyzed by 
Western blotting. The results indicated that Survivin gene 
expression obviously decreased as the EGB concentration 
increased, showing significant dose-effect relationship. This 
study presumed that the mechanism and molecular basis of 
EGB inducing ACC-2 apoptosis maybe as follows: First, EGB 
inhibits Survivin gene expression in cell apoptosis pathway, 
then Caspase activity is inhibited accordingly, at last, signal 
transduction pathway of cell apoptosis is activated.
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